0
0
2019 Scientific Sessions On-Demand
Late Breaking Science VI: New Frontiers in Lipid Therapy
Nov 18, 2019 9:00am ‐ Nov 18, 2019 10:15am
Credits: None available.
Standard: $35.00
Members: $25.00
Members: $25.00
Effect of Icosapent Ethyl on Progression of Coronary Atherosclerosis in Patients With Elevated Triglycerides (200-499mg/dl) on Statin Therapy (EVAPORATE Study)
09:00am - 10:15am
Matthew Budoff
09:00am - 10:15am
Matthew Budoff
Safety and Efficacy of Inclisiran in Patients With Heterozygous Familial Hypercholesterolemia - Results From the Phase 3 ORION-9 Trial
09:00am - 10:15am
Frederick Raal
09:00am - 10:15am
Frederick Raal
RNA Interference Targeting Apolipoprotein C-III Results in Deep and Prolonged Reductions in Plasma Triglycerides
09:00am - 10:15am
Christian Schwabe
09:00am - 10:15am
Christian Schwabe
RNA Interference Targeting Hepatic Angiopoietin-Like Protein 3 Results in Prolonged Reductions in Plasma Triglycerides and LDL-C in Human Subjects
09:00am - 10:15am
Gerald Watts
09:00am - 10:15am
Gerald Watts
Benefit of a Target LDL Cholesterol Less Than 70 mg/dl After an Ischemic Stroke of Atherosclerotic Origin, the Treat Stroke to Target Trial Results
09:00am - 10:15am
Pierre Amarenco
09:00am - 10:15am
Pierre Amarenco
Credits
Credits: None available.You must be logged in and own this session in order to post comments.